Prostate Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Preliminary Tests, Confirmatory Tests), By Type (Adenocarcinoma, Interstitial Cell Carcinoma, Other), By End Use, By Region, And Segment Forecasts, 2024 - 2030

Market Segmentation

• Prostate Cancer Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Preliminary Tests
    • PSA Tests
    • Free PSA Test
    • Total PSA Test
    • Other Preliminary Tests
  • Confirmatory Tests
    • Pca3 Test
    • Trans-Rectal Ultrasound
    • Biopsy Test
• Prostate Cancer Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Adenocarcinoma
  • Interstitial Cell Carcinoma
  • Other
• Prostate Cancer Diagnostics End Use Outlook (Revenue, USD Million; 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
  • Home Care
  • Research & Manufacturing
• Prostate Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Prostate Cancer Diagnostics, By Test Type
      • Preliminary Tests
        • PSA Tests
        • Free PSA Test
        • Total PSA Test
        • Other Preliminary Tests
      • Confirmatory Tests
        • Pca3 Test
        • Trans-Rectal Ultrasound
        • Biopsy Test
    • North America Prostate Cancer Diagnostics, By Type
      • Adenocarcinoma
      • Interstitial Cell Carcinoma
      • Other
    • North America Prostate Cancer Diagnostics, By End Use
      • Hospitals
      • Outpatient Facilities
      • Home Care
      • Research & Manufacturing
    • U.S.
      • U.S. Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • U.S. Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • U.S. Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Canada
      • Canada Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Canada Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Canada Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
  • Europe
    • Europe Prostate Cancer Diagnostics, By Test Type
      • Preliminary Tests
        • PSA Tests
        • Free PSA Test
        • Total PSA Test
        • Other Preliminary Tests
      • Confirmatory Tests
        • Pca3 Test
        • Trans-Rectal Ultrasound
        • Biopsy Test
    • Europe Prostate Cancer Diagnostics, By Type
      • Adenocarcinoma
      • Interstitial Cell Carcinoma
      • Other
    • Europe Prostate Cancer Diagnostics, By End Use
      • Hospitals
      • Outpatient Facilities
      • Home Care
      • Research & Manufacturing
    • UK
      • UK Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • UK Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • UK Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Germany
      • Germany Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Germany Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Germany Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • France
      • France Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • France Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • France Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Italy
      • Italy Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Italy Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Italy Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Spain
      • Spain Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Spain Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Spain Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Denmark
      • Denmark Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Denmark Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Denmark Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Sweden
      • Sweden Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Sweden Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Sweden Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Norway
      • Norway Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Norway Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Norway Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
  • Asia Pacific
    • Asia Pacific Prostate Cancer Diagnostics, By Test Type
      • Preliminary Tests
        • PSA Tests
        • Free PSA Test
        • Total PSA Test
        • Other Preliminary Tests
      • Confirmatory Tests
        • Pca3 Test
        • Trans-Rectal Ultrasound
        • Biopsy Test
    • Asia Pacific Prostate Cancer Diagnostics, By Type
      • Adenocarcinoma
      • Interstitial Cell Carcinoma
      • Other
    • Asia Pacific Prostate Cancer Diagnostics, By End Use
      • Hospitals
      • Outpatient Facilities
      • Home Care
      • Research & Manufacturing
    • China
      • China Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • China Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • China Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Japan
      • Japan Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Japan Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Japan Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • India
      • India Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • India Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • India Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Australia
      • Australia Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Australia Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Australia Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Thailand
      • Thailand Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Thailand Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Thailand Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • South Korea
      • South Korea Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • South Korea Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • South Korea Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
  • Latin America
    • Latin America Prostate Cancer Diagnostics, By Test Type
      • Preliminary Tests
        • PSA Tests
        • Free PSA Test
        • Total PSA Test
        • Other Preliminary Tests
      • Confirmatory Tests
        • Pca3 Test
        • Trans-Rectal Ultrasound
        • Biopsy Test
    • Latin America Prostate Cancer Diagnostics, By Type
      • Adenocarcinoma
      • Interstitial Cell Carcinoma
      • Other
    • Latin America Prostate Cancer Diagnostics, By End Use
      • Hospitals
      • Outpatient Facilities
      • Home Care
      • Research & Manufacturing
    • Brazil
      • Brazil Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Brazil Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Brazil Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Mexico
      • Mexico Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Mexico Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Mexico Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Argentina
      • Argentina Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Argentina Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Argentina Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
  • Middle East & Africa
    • Middle East & Africa Prostate Cancer Diagnostics, By Test Type
      • Preliminary Tests
        • PSA Tests
        • Free PSA Test
        • Total PSA Test
        • Other Preliminary Tests
      • Confirmatory Tests
        • Pca3 Test
        • Trans-Rectal Ultrasound
        • Biopsy Test
    • Middle East & Africa Prostate Cancer Diagnostics, By Type
      • Adenocarcinoma
      • Interstitial Cell Carcinoma
      • Other
    • Middle East & Africa Prostate Cancer Diagnostics, By End Use
      • Hospitals
      • Outpatient Facilities
      • Home Care
      • Research & Manufacturing
    • South Africa
      • South Africa Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • South Africa Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • South Africa Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Saudi Arabia
      • Saudi Arabia Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Saudi Arabia Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Saudi Arabia Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • UAE
      • UAE Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • UAE Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • UAE Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing
    • Kuwait
      • Kuwait Prostate Cancer Diagnostics, By Test Type
        • Preliminary Tests
          • PSA Tests
          • Free PSA Test
          • Total PSA Test
          • Other Preliminary Tests
        • Confirmatory Tests
          • Pca3 Test
          • Trans-Rectal Ultrasound
          • Biopsy Test
      • Kuwait Prostate Cancer Diagnostics, By Type
        • Adenocarcinoma
        • Interstitial Cell Carcinoma
        • Other
      • Kuwait Prostate Cancer Diagnostics, By End Use
        • Hospitals
        • Outpatient Facilities
        • Home Care
        • Research & Manufacturing

Prostate Cancer Diagnostics Market Dynamics

Driver: Increasing prevalence of prostate cancer

The market growth is anticipated to be driven by the increase in the prevalence of prostate cancer during the forecast period. In 2020, the American Cancer Society estimated that approximately 191,930 new cases of prostate cancer would be diagnosed in the United States. It is projected that around 1 in every nine men will receive a prostate cancer diagnosis during their lifetime. Prostate cancer ranks among the leading causes of death in the United States, with an estimated 33,330 deaths expected in 2020. However, the 5-year survival rate for men diagnosed with this disease in the United States is 99%. Prostate cancer is more commonly found in men aged 65 or older, while it is scarce among men below 40 years of age. According to Cancer Research UK, there were 47,151 new cases of prostate cancer diagnosed in 2015. Additionally, the Australian Institute of Health and Welfare reported that prostate cancer was the third most common cause of death in Australia in 2014. Global data from the World Cancer Research Fund reveals that approximately 1.3 million cases of prostate cancer were diagnosed worldwide in 2018. As the number of deaths caused by prostate cancer continues to rise, there is an increasing demand for rapid and accurate diagnosis, which is expected to fuel market growth further.

Driver: Increasing government initiatives

The Asia Pacific branch of the Prostate Cancer Patient Coalition is comprised of five patient organizations: The Prostate Cancer Foundation of Australia, the China Primary Health Care Foundation, Senyu Club in Japan, the Prostate Cancer Patient Association in Korea, and the Prostate Cancer Prevention Association in Taiwan. This coalition was established in 2017 to address the challenges faced by men living with prostate cancer. In 2015, Governor Edmund G. Brown Jr of California announced the launch of the California Initiative to Advance Precision Medicine (CIAPM), which had a budget of USD 30 million for the 2018-2019 fiscal year. Prostate cancer was chosen as one of the demonstration projects under CIAPM. This initiative aims to develop the necessary infrastructure and resources to support precision medicine efforts in the state. In the United States, September is recognized as National Prostate Cancer Awareness Month to raise awareness about the condition. In 2013, the Australian government allocated USD 6.2 million to the Australian Prostate Cancer Research Center in Queensland to expand the number of prostate cancer research centers nationwide. In 2018, a study called RESPOND (Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress) was launched with a funding of USD 26.5 million. This study, supported by the National Institute on Minority Health and Health Disparities (NIMHD) and the National Cancer Institute (NCI), aims to investigate the nonbiological and biological factors related to aggressive prostate cancer in African American men.

Restraint: High cost of diagnosis

Prostate cancer remains a significant cause of mortality worldwide, yet the high expenses associated with diagnosing and treating this disease hinder the growth of the market. For example, the cost of mpMRI ranges from USD 1,000 to USD 2,000, while genetic testing can amount to USD 3,000 to USD 4,000. In the United States, prostate MRI prices vary from USD 500 to USD 2,500, depending on insurance coverage or reimbursement availability. Weill Cornell Medicine reports that approximately 1 million American men undergo prostate biopsies each year. If all these patients were to receive MRI instead of alternative methods, the total annual cost of diagnosis could potentially reach USD 3 billion. Moreover, reimbursement coverage differs across countries due to the policies of private insurance companies, leading to increased expenses in underdeveloped economies with unclear reimbursement guidelines for prostate cancer diagnosis.

What Does This Report Include?

This section will provide insights into the contents included in this prostate cancer diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Prostate cancer diagnostics market qualitative analysis

• Industry overview

• Industry trends

• Market drivers and restraints

• Market size

• Growth prospects

• Porter’s analysis

• PESTEL analysis

• Key market opportunities prioritized

• Competitive landscape

  • Company overview

  • Financial performance

  • Product benchmarking

  • Latest strategic developments

Prostate cancer diagnostics market quantitative analysis

• Market size, estimates, and forecast from 2018 to 2030

• Market estimates and forecast for product segments up to 2030

• Regional market size and forecast for product segments up to 2030

• Market estimates and forecast for application segments up to 2030

• Regional market size and forecast for application segments up to 2030

• Company financial performance